Other complications following infusion, transfusion and therapeutic injection
Notes: Infiltration of vesicant agent ; Infiltration of vesicant antineoplastic chemotherapy ; Infiltration of other vesicant agent ; Complication of chimeric antigen receptor (CAR-T) cell therapy ; Complication of IEC therapy ; Delayed serologic transfusion reaction (DSTR), unspecified incompatibility ; code to identify the specific complication, such as: ; cytokine release syndrome (D89.83-) ; immune effector cell-associated neurotoxicity syndrome (G92.0-) ; code to identify graft-versus-host reaction, if applicable, (D89.81-) ; complication of bone marrow transplant (T86.0) ; complication of stem cell transplant (T86.5)